Skip to content

The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial

The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00566072
Enrollment
21
Registered
2007-12-03
Start date
2001-05-31
Completion date
2003-05-31
Last updated
2007-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cytomegalovirus Infections

Keywords

the effect of information on compliance of medication

Brief summary

21 patients were randomised to receive instructions and coaching or no intervention on the use and intake of ganciclovir. Intake of medication was measured by an electronic pill box. The duration of the study was 100 days.

Interventions

BEHAVIORALinstructions and coaching

instructions and coaching or no intervention on the use and intake of ganciclovir

Sponsors

Hoffmann-La Roche
CollaboratorINDUSTRY
University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* men and women between 18 and 65 years old * de novo kidney transplant patients * patients who need CMV prophylaxis with ganciclovir during 3 months * patients who gave informed consent after an oral explanation of the study

Exclusion criteria

* patients who are seronegative for CMV virus and who received a kidney from a CMV negative donor * patients with a creatinin clearance of less than 10 ml/min

Design outcomes

Primary

MeasureTime frame
relation between compliance of medication towards chemoprophylaxis and occurrence of CMV infection after kidney transplantationweekly follow-up

Secondary

MeasureTime frame
relation between compliance and the instructions which a patient gets about intake of medicationweekly follow-up

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026